Researchers in the United States have identified both antigen-specific and antigen non-specific predictive signatures of antibody responses to Moderna’s two-dose coronavirus disease 2019 (COVID-19) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback